Truist raised the firm’s price target on Curtiss-Wright to $250 from $225 and keeps a Buy rating on the shares. After hosting investor meetings with Curtiss-Wright management earlier this week, Truist believes the company’s multiple opportunities within commercial nuclear have the power to drive transformative growth longer-term, the analyst tells investors in a research note. In the near-term, Truist expects that strong execution across the company’s portfolio will support continued organic growth and margin expansion, and believes increased M&A activity in 2024 to be a potential upside catalyst.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CW:
- William Blair says buy these stocks for 2024
- Curtiss-Wright price target raised to $243 from $227 at Stifel
- Curtiss-Wright price target raised to $225 from $215 at Truist
- Curtiss-Wright raises FY23 EPS view to $9.00-$9.20, consensus $9.10
- Curtiss-Wright reports Q3 adjusted EPS $2.54, consensus $2.38